Skip to Main Content

Paper Details

Succinate Mediates Tumorigenic Effects <i>via</i> Succinate Receptor 1: Potential for New Targeted Treatment Strategies in Succinate Dehydrogenase Deficient Paragangliomas.
Front Endocrinol (Lausanne)
23
2021
ERK, PPGLs, Paragangliomas, SDHB, SDHD, SDHD head and neck paragangliomas, SDHx, SDHx PPGLs, SUCNR1, SUCNR1-transfected PC12, Succinate, Succinate Dehydrogenase, Succinate Dehydrogenase Deficient Paragangliomas, Succinate Receptor 1, catecholamine, chromaffin, chromaffin tumors, control cells, hPheo1, human, patients, pheochromocytoma, pheochromocytomas, progenitor cells, succinate, succinate dehydrogenase subunit A-D, succinate receptor 1, therapeutic
Author NameAffiliation
Maria J MerinoNational Cancer Institute, National Institutes of Health
Maria J MerinoNational Cancer Institute, National Institutes of Health
Zhengping ZhuangNational Institute of Neurological Disorders and Stroke, National Institutes of Health
Karel PacakEunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health
  • 1 - 4

Datasets

Release 1.2